Covid-19 Clinical Trial
Official title:
Psychosocial Care During the COVID-19 Pandemic in Acute Hospitals - an International Online Survey of Psychosomatic, Psychiatric and Psychological Consultation and Liaison (C&L) Services
Verified date | October 2021 |
Source | University Hospital, Basel, Switzerland |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Heads of all psychosomatic, psychiatric and psychological consultation and liaison (C&L) services in acute care hospitals across all participating countries will be contacted and asked to participate in this international cross-sectional online survey. The survey consists of questions about care structures and their utilisation that psychosomatic, psychiatric and psychological C&L services have established in acute hospitals in the context of the COVID 19 pandemic.
Status | Completed |
Enrollment | 230 |
Est. completion date | October 3, 2021 |
Est. primary completion date | October 3, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - heads of all psychosomatic, psychiatric and psychological C&L services in acute care hospitals across all participating countries Exclusion Criteria: - None |
Country | Name | City | State |
---|---|---|---|
Austria | Medical University of Graz, University Hospital Graz | Graz | Steiermark |
Belgium | Ghent University Hospital, Department of Psychiatry | Ghent | |
Canada | University of Montreal, Department of Psychosomatic Medicine | Montreal | |
Canada | TorontoSinai Health, University of Toronto, Department of Psychiatry | Toronto | |
Finland | Oulu University Hospital and University of Oulu | Oulu | |
France | Université de Paris, Service de Psychiatrie de l'adulte | Paris | |
Germany | University Hospital Cologne, Department of Psychosomatics and Psychotherapy | Köln | Nordrhein-Westfalen |
Germany | Nuremberg Hospital, Department of Psychosomatic Medicine and Psychotherapy | Nürnberg | Bayern |
Greece | Aristotle University Thessaloniki | Thessaloniki | |
Iran, Islamic Republic of | University of Medical Sciences, Department of Psychiatry | Tehran | |
Ireland | University College Dublin | Dublin | |
Italy | Bologna University | Bologna | |
Italy | University of Modena & Reggio Emilia | Modena | |
Norway | Oslo University Hospital | Oslo | |
Poland | Wroclaw Medical University | Wroclaw | |
Portugal | Hospital de Santa Maria | Lisboa | |
Portugal | Universidade Católica Portuguesa Lisboa | Lisboa | |
Spain | Barcelona University | Barcelona | |
Switzerland | University Hospital Basel, Department of Psychosomatic Medicine | Basel | Basel-City |
Switzerland | University of Basel, Department of Psychiatry (UPK) | Basel | |
United Kingdom | University of Exeter | Exeter | |
United Kingdom | University of York | York |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Basel, Switzerland |
Austria, Belgium, Canada, Finland, France, Germany, Greece, Iran, Islamic Republic of, Ireland, Italy, Norway, Poland, Portugal, Spain, Switzerland, United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Structural and process quality of COVID-19 related psychosocial C&L services | Data basis for improving quality of COVID-19 related psychosocial C&L services:
characterization of participating C&L services involvement of respective hospitals in the physical care of COVID-19 patients structures/ organization of psychosocial care for COVID-19 patients in participating hospitals specific psychosocial support established in participating hospitals in context of COVID-19 for patients relatives staff communication strategies - How the different target groups were informed about COVID-19 related psychosocial support services and offers burden of COVID-19 pandemic on psychosocial C&L teams needs and wishes of the participating psychosocial C&L services for support or exchange of experience regarding psychosocial care in the COVID 19 context for changes / improvements considered essential for the future with regard to psychosocial care services in the participating hospitals in the COVID-19 context |
6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT06065033 -
Exercise Interventions in Post-acute Sequelae of Covid-19
|
N/A | |
Completed |
NCT06267534 -
Mindfulness-based Mobile Applications Program
|
N/A | |
Completed |
NCT05047601 -
A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection
|
Phase 2/Phase 3 | |
Recruiting |
NCT04481633 -
Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection
|
N/A | |
Recruiting |
NCT05323760 -
Functional Capacity in Patients Post Mild COVID-19
|
N/A | |
Completed |
NCT04612972 -
Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru
|
Phase 3 | |
Completed |
NCT04537949 -
A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults
|
Phase 1/Phase 2 | |
Recruiting |
NCT05494424 -
Cognitive Rehabilitation in Post-COVID-19 Condition
|
N/A | |
Active, not recruiting |
NCT06039449 -
A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2
|
Phase 3 | |
Enrolling by invitation |
NCT05589376 -
You and Me Healthy
|
||
Completed |
NCT05158816 -
Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
|
||
Recruiting |
NCT04341506 -
Non-contact ECG Sensor System for COVID19
|
||
Completed |
NCT04512079 -
FREEDOM COVID-19 Anticoagulation Strategy
|
Phase 4 | |
Completed |
NCT04384445 -
Zofin (Organicell Flow) for Patients With COVID-19
|
Phase 1/Phase 2 | |
Completed |
NCT05975060 -
A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants.
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT05542862 -
Booster Study of SpikoGen COVID-19 Vaccine
|
Phase 3 | |
Terminated |
NCT05487040 -
A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease
|
Phase 1 | |
Withdrawn |
NCT05621967 -
Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation
|
N/A | |
Terminated |
NCT04498273 -
COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80
|
Phase 3 | |
Active, not recruiting |
NCT06033560 -
The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure
|